| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alleviating experimental pulmonary hypertension via co-delivering FoxO1 stimulus and apoptosis activator to hyperproliferating pulmonary arteries
|
Li, Bingbing
|
|
|
13 |
6 |
p. 2369-2382
|
artikel
|
| 2 |
Antitumor activity of aumolertinib, a third-generation EGFR tyrosine kinase inhibitor, in non-small-cell lung cancer harboring uncommon EGFR mutations
|
Shi, Chen
|
|
|
13 |
6 |
p. 2613-2627
|
artikel
|
| 3 |
Author correction to ‘Discovery of the radio-protecting effect of ecliptae herba, its constituents and targeting p53-mediated apoptosis in vitro and in vivo’ [Acta Pharm Sin B 13 (2023) 1216–1230]
|
Wu, Jiang
|
|
|
13 |
6 |
p. 2815-2816
|
artikel
|
| 4 |
Bone-derived MSCs encapsulated in alginate hydrogel prevent collagen-induced arthritis in mice through the activation of adenosine A2A/2B receptors in tolerogenic dendritic cells
|
Shi, Gaona
|
|
|
13 |
6 |
p. 2778-2794
|
artikel
|
| 5 |
Building bioorthogonal click-release capable artificial receptors on cancer cell surface for imaging, drug targeting and delivery
|
Chen, Jing
|
|
|
13 |
6 |
p. 2736-2746
|
artikel
|
| 6 |
Commentary: A nearly forgotten class of anti-inflammatory lipid molecules in central nervous system
|
Ru, Nan
|
|
|
13 |
6 |
p. 2809-2811
|
artikel
|
| 7 |
Commentary: Inhibitors of mitochondrial respiratory chain in the treatment of type 2 diabetes
|
Ye, Jianping
|
|
|
13 |
6 |
p. 2807-2808
|
artikel
|
| 8 |
Corynoxine B targets at HMGB1/2 to enhance autophagy for α-synuclein clearance in fly and rodent models of Parkinson's disease
|
Zhu, Qi
|
|
|
13 |
6 |
p. 2701-2714
|
artikel
|
| 9 |
Cover Story
|
|
|
|
13 |
6 |
p. xii
|
artikel
|
| 10 |
Discovery of novel exceptionally potent and orally active c-MET PROTACs for the treatment of tumors with MET alterations
|
Li, Pengyun
|
|
|
13 |
6 |
p. 2715-2735
|
artikel
|
| 11 |
Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles
|
Gao, Shenghua
|
|
|
13 |
6 |
p. 2747-2764
|
artikel
|
| 12 |
Editorial of Special Column on Delivery Nanotechnologies to Modulate the Immune System and Combat Inflammation and Infection
|
He, Wei
|
|
|
13 |
6 |
p. 2296-2297
|
artikel
|
| 13 |
Editor Profile: Guest Editor of Special Column on Delivery Nanotechnologies to Modulate the Immune System and Combat Inflammation and Infection
|
|
|
|
13 |
6 |
p. 2295
|
artikel
|
| 14 |
Emerging trends in organ-on-a-chip systems for drug screening
|
Wang, Yanping
|
|
|
13 |
6 |
p. 2483-2509
|
artikel
|
| 15 |
ETCM v2.0: An update with comprehensive resource and rich annotations for traditional Chinese medicine
|
Zhang, Yanqiong
|
|
|
13 |
6 |
p. 2559-2571
|
artikel
|
| 16 |
Five trends of China's pharmaceutical industry in 2022
|
Chen, Yue
|
|
|
13 |
6 |
p. 2812-2814
|
artikel
|
| 17 |
Functional biomaterials for comprehensive periodontitis therapy
|
Luan, Jiayi
|
|
|
13 |
6 |
p. 2310-2333
|
artikel
|
| 18 |
GSDMD in peripheral myeloid cells regulates microglial immune training and neuroinflammation in Parkinson's disease
|
Wang, Bingwei
|
|
|
13 |
6 |
p. 2663-2679
|
artikel
|
| 19 |
Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer
|
Wang, Xiaomin
|
|
|
13 |
6 |
p. 2601-2612
|
artikel
|
| 20 |
Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis
|
Yu, Qian
|
|
|
13 |
6 |
p. 2628-2644
|
artikel
|
| 21 |
Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis
|
Zhu, Lingling
|
|
|
13 |
6 |
p. 2464-2482
|
artikel
|
| 22 |
Intelligent nanotherapeutic strategies for the delivery of CRISPR system
|
Chen, Chao
|
|
|
13 |
6 |
p. 2510-2543
|
artikel
|
| 23 |
Light-responsive nanomedicine for cancer immunotherapy
|
Kang, Weirong
|
|
|
13 |
6 |
p. 2346-2368
|
artikel
|
| 24 |
Manipulation of IME4 expression, a global regulation strategy for metabolic engineering in Saccharomyces cerevisiae
|
Zhu, Jianxun
|
|
|
13 |
6 |
p. 2795-2806
|
artikel
|
| 25 |
Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
|
Zhang, Wenxin
|
|
|
13 |
6 |
p. 2585-2600
|
artikel
|
| 26 |
MF-SuP-pK a: Multi-fidelity modeling with subgraph pooling mechanism for pK a prediction
|
Wu, Jialu
|
|
|
13 |
6 |
p. 2572-2584
|
artikel
|
| 27 |
Novel discovery of schisandrin A regulating the interplay of autophagy and apoptosis in oligoasthenospermia by targeting SCF/c-kit and TRPV1 via biosensors
|
Ma, Lijuan
|
|
|
13 |
6 |
p. 2765-2777
|
artikel
|
| 28 |
Opportunities and challenges of incretin-based hypoglycemic agents treating type 2 diabetes mellitus from the perspective of physiological disposition
|
Xie, Yaochen
|
|
|
13 |
6 |
p. 2383-2402
|
artikel
|
| 29 |
Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling
|
Peng, Kezheng
|
|
|
13 |
6 |
p. 2680-2700
|
artikel
|
| 30 |
Pathophysiology of obesity and its associated diseases
|
Jin, Xin
|
|
|
13 |
6 |
p. 2403-2424
|
artikel
|
| 31 |
Recent progress in application of nanovaccines for enhancing mucosal immune responses
|
Du, Guangsheng
|
|
|
13 |
6 |
p. 2334-2345
|
artikel
|
| 32 |
Table of Contents
|
|
|
|
13 |
6 |
p. iii-xii
|
artikel
|
| 33 |
Targeting histone deacetylases for cancer therapy: Trends and challenges
|
Liang, Tao
|
|
|
13 |
6 |
p. 2425-2463
|
artikel
|
| 34 |
The feasibility of oral targeted drug delivery: Gut immune to particulates?
|
Ren, Yuehong
|
|
|
13 |
6 |
p. 2544-2558
|
artikel
|
| 35 |
The suppression of cervical cancer ferroptosis by macrophages: The attenuation of ALOX15 in cancer cells by macrophages-derived exosomes
|
Luo, Yanlin
|
|
|
13 |
6 |
p. 2645-2662
|
artikel
|
| 36 |
Wearable patches for transdermal drug delivery
|
He, Jiahui
|
|
|
13 |
6 |
p. 2298-2309
|
artikel
|
Tijdschrift beschrijving